Lensar (LNSR) Return on Capital Employed Growth (1y) (2021 - 2026)
Lensar (LNSR) Return on Capital Employed Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 125.00 |
| 10 | Lensar | 65.43 Mn | 54.33 Mn | 6.38 Mn | -39.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.00 |
| Dec 31, 2025 | -5,957.00 |
| Sep 30, 2025 | -3,592.00 |
| Jun 30, 2025 | -1,054.00 |
| Mar 31, 2025 | -1,338.00 |
| Dec 31, 2024 | -82.00 |
| Sep 30, 2024 | -486.00 |
| Jun 30, 2024 | 270.00 |
| Mar 31, 2024 | 2,199.00 |
| Dec 31, 2023 | 2,509.00 |
| Sep 30, 2023 | 2,593.00 |
| Jun 30, 2023 | 2,151.00 |
| Mar 31, 2023 | -266.00 |
| Dec 31, 2022 | -1,241.00 |
| Sep 30, 2022 | -945.00 |
| Jun 30, 2022 | -1,643.00 |
| Mar 31, 2022 | -874.00 |
| Dec 31, 2021 | -766.00 |